Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K. Mochimaru H, et al. Among authors: tsukamoto n. Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4410-5. doi: 10.1167/iovs.08-3044. Epub 2009 Apr 1. Invest Ophthalmol Vis Sci. 2009. PMID: 19339747 Free article.
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.
Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y. Okabayashi K, et al. Among authors: tsukamoto n. Cancer Sci. 2012 Sep;103(9):1617-24. doi: 10.1111/j.1349-7006.2012.02355.x. Epub 2012 Jul 16. Cancer Sci. 2012. PMID: 22676270 Free PMC article.
CCL2 is critical for immunosuppression to promote cancer metastasis.
Kudo-Saito C, Shirako H, Ohike M, Tsukamoto N, Kawakami Y. Kudo-Saito C, et al. Among authors: tsukamoto n. Clin Exp Metastasis. 2013 Apr;30(4):393-405. doi: 10.1007/s10585-012-9545-6. Epub 2012 Nov 11. Clin Exp Metastasis. 2013. PMID: 23143679
Immune-resistant mechanisms in cancer immunotherapy.
Kawakami Y, Ohta S, Sayem MA, Tsukamoto N, Yaguchi T. Kawakami Y, et al. Among authors: tsukamoto n. Int J Clin Oncol. 2020 May;25(5):810-817. doi: 10.1007/s10147-019-01611-x. Epub 2020 Jan 9. Int J Clin Oncol. 2020. PMID: 31919690 Review.
Dendritic cell based personalized immunotherapy based on cancer antigen research.
Kawakami Y, Fujita T, Kudo C, Sakurai T, Udagawa M, Yaguchi T, Hasegawa G, Hayashi E, Ueda Y, Iwata T, Wang Q, Okada S, Tsukamoto N, Matsuzaki Y, Sumimoto H. Kawakami Y, et al. Among authors: tsukamoto n. Front Biosci. 2008 Jan 1;13:1952-8. doi: 10.2741/2814. Front Biosci. 2008. PMID: 17981682 Review.
The mechanisms of cancer immunoescape and development of overcoming strategies.
Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, Iwata-Kajihara T, Nishio H, Kawamura N, Kawakami Y. Yaguchi T, et al. Among authors: tsukamoto n. Int J Hematol. 2011 Mar;93(3):294-300. doi: 10.1007/s12185-011-0799-6. Epub 2011 Mar 5. Int J Hematol. 2011. PMID: 21374075 Review.
[Immunotherapy targeting cancer stem cells].
Kawakami Y, Matsushita M, Ueda R, Tsukamoto N, Ohta S. Kawakami Y, et al. Among authors: tsukamoto n. Nihon Rinsho. 2012 Dec;70(12):2142-6. Nihon Rinsho. 2012. PMID: 23259387 Review. Japanese.
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T, Kudo-Saito C, Muramatsu R, Fujita T, Saito M, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Hayashi Y, Kaseda K, Kamiyama I, Ohtsuka T, Tomizawa K, Shimoji M, Mitsudomi T, Asamura H, Kawakami Y. Kinoshita T, et al. Among authors: tsukamoto n. Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23. Eur J Cancer. 2017. PMID: 28950145
512 results